Research. Strategy. Systems Design. AI.

The tell this week wasn't a benchmark. OpenAI shipped GPT-6 Astra on Wednesday at ten dollars in, fifty out — the fourth frontier model in 72 hours, after Fable 5.1, Gemini 3.8 Flash and Muse Spark 1.3 — and about the only people who noticed were the ones repricing their API bills. When a top-tier model lands every couple of days, “how smart” stops being the interesting question. The interesting question is whether the world can supply what the smart thing eats, and whether the neighbors will keep letting it eat.

Power first, because it's the hardest wall. PJM — the grid for about 65 million people — came up 6.8 gigawatts short and is running the first backstop auction in its 18-year history, hunting up to 15 gigawatts of new generation to plug a hole that barely existed a few auctions ago. Capacity's clearing at roughly ten times what it cost two years back. The hyperscalers' fix is to stop asking the grid: more nuclear signed in eighteen months — 9.8-plus gigawatts across 13 deals — than the country managed in the prior twenty years. Except almost none of that steel is hot yet. The first restart doesn't feed a data center until 2027.

Then the inputs and the neighbors, tightening together. China widened its rare-earth licensing again — samarium, gadolinium, lutetium — and floated a rule that any foreign product with even a trace of Chinese-origin material needs a license; enforcement's paused until November, which is a countdown, not a reprieve. And the neighbors have found the one number that turns a zoning fight into a campaign: the electric bill. Utilities asked for $9.4 billion in rate hikes in just the first three months of the year, bills are up better than seven percent, and roughly seven in ten people now say keep the data center out of my town. That's on the ballot in four states.

Off to the side, two forces that don't file paperwork. NOAA now thinks the El Niño becomes the strongest on record this month — not next year, this month — peaking through winter no matter what any auction clears. And in the clinic, Intellia's one-shot CRISPR became the first in-body gene edit to clear a Phase 3, a single infusion that rewrites a gene and holds. One wrecks things on a physical clock; the other fixes them on a regulatory one. Neither is waiting in an interconnection queue.

So the next two years don't look like a leaderboard. They look like a wall of due dates — PJM this month, China in November, the El Niño peak this winter, the orbital data centers nobody's really flown pushed out to 2027. The models keep getting cheaper and better the whole way through. That just stopped being the variable that decides anything.